XML 45 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value - Additional Information (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Apr. 07, 2022
Dec. 31, 2021
USD ($)
Oct. 31, 2024
USD ($)
Jul. 31, 2024
USD ($)
Installment
Apr. 30, 2024
USD ($)
Installment
Jul. 31, 2023
USD ($)
Installment
Jul. 31, 2022
USD ($)
Apr. 30, 2022
USD ($)
Installment
Jun. 30, 2022
USD ($)
Installment
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
Installment
Jun. 30, 2021
USD ($)
Dec. 31, 2018
USD ($)
Installment
shares
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                          
Interest expense due to passage of time and fixed payment schedule                 $ 1,100        
Reduction in contingent consideration                 1,000        
Loss on debt extinguishment               $ (18) (2,952)   $ (2,952) $ (728)  
Second Amendment                          
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                          
Repayments of Debt   $ 20,000                 $ 20,000    
Milestone payment   $ 4,600                      
Interest Expense                          
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                          
Loss on debt extinguishment                 (2,900)        
Interest Expense | Discount Rate                          
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                          
Changes in fair value                 $ 100        
Integrated Diagnostics, Inc                          
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                          
Business acquisition description                     requires additional consideration to be paid by the Company to such shareholders upon attainment of a three-consecutive month    
Business acquisition contingent consideration gross margin target                   $ 2,000     $ 2,000
Business acquisition contingent consideration gross margin target period                         7 years
Integrated Diagnostics, Inc | Third Amendment to APA Agreement                          
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                          
Contingent consideration number of installments | Installment               5          
Milestone payment               $ 2,000          
Percentage of interest on installment payments 10.00%                        
Integrated Diagnostics, Inc | Subsequent Event | Third Amendment to APA Agreement                          
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                          
Third milestone and interest payment Made             $ 2,100            
Integrated Diagnostics, Inc | Scenario Forecast | Third Amendment to APA Agreement                          
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                          
Contingent consideration number of installments | Installment       1 1 3              
Milestone payment       $ 8,400 $ 5,000 $ 3,000              
Exit fee payment     $ 6,100                    
Integrated Diagnostics, Inc | Common Stock                          
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                          
Business acquisition description                     If Indi elected to not exercise its option, the Company had 12 months to repurchase the common stock in two equal and consecutive quarterly cash installments totaling $37.0 million.    
Contingent consideration shares | shares                         2,520,108
Contingent consideration number of installments | Installment                 6   6   8
Contingent consideration arrangements, common shares, redemption amount                     $ 4,600   $ 37,000
Repayments of Debt                     9,300    
Business combination contingent consideration final payment                     $ 37,000    
Integrated Diagnostics, Inc | Common Stock | Repurchase                          
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                          
Contingent consideration number of installments | Installment                         2
Contingent consideration cash payment                         $ 37,000
Minimum                          
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                          
Percentage of probabilities of contingent consideration successful achievement of specified product gross margin targets discount rates range                     11.00%    
Maximum                          
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                          
Percentage of probabilities of contingent consideration successful achievement of specified product gross margin targets discount rates range                     16.00%